Biosafety and antioxidant effects of a beverage containing silymarin and arginine. A pilot, human intervention cross-over trial
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu klinické zkoušky, časopisecké články, práce podpořená grantem
PubMed
23439479
DOI
10.1016/j.fct.2013.02.023
PII: S0278-6915(13)00132-4
Knihovny.cz E-zdroje
- MeSH
- antioxidancia aplikace a dávkování MeSH
- arginin aplikace a dávkování MeSH
- dospělí MeSH
- erytrocyty účinky léků metabolismus MeSH
- gama-glutamyltransferasa krev MeSH
- glutathion krev MeSH
- glutathionperoxidasa krev MeSH
- glutathionreduktasa krev MeSH
- glutathiontransferasa krev MeSH
- katalasa krev MeSH
- klinické křížové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- malondialdehyd krev MeSH
- nápoje * MeSH
- pilotní projekty MeSH
- potravní doplňky * MeSH
- silibinin MeSH
- silymarin aplikace a dávkování MeSH
- superoxiddismutasa krev MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antioxidancia MeSH
- arginin MeSH
- gama-glutamyltransferasa MeSH
- glutathion MeSH
- glutathionperoxidasa MeSH
- glutathionreduktasa MeSH
- glutathiontransferasa MeSH
- katalasa MeSH
- malondialdehyd MeSH
- silibinin MeSH
- silymarin MeSH
- superoxiddismutasa MeSH
The study objective was to investigate the potential of a beverage containing silymarin and L-arginine to alter basic physiological and urodynamic parameters in 22 normal healthy men aged 38-59 years. The volunteers drank 500 ml/day beverage without silymarin and L-arginine for 10 days followed, after a 7-day washout period, by the beverage with 400mg silymarin and 295 mg L-arginine for 10 days. Blood and urine samples were collected on days 0, 10 and 27. The beverages were well-tolerated with no adverse effects. Most of the biochemical, hematological and urodynamic parameters remained unchanged. Total antioxidant capacity, total level of antioxidants, lipoperoxidation products (malondialdehyde), advanced oxidation products of proteins in plasma and glutathione, glutathione peroxidase, glutathione reductase, superoxide dismutase and catalase levels in erythrocytes were not influenced. Serum γ-glutamyl transferase, malondialdehyde level and activity of glutathione S-transferase in erythrocytes were lowered at day 27 and the concentration of total plasma SH-groups was higher on day 10. Using an ex vivo system, we found that silymarin/silybin at 10-100 μM is able to adsorb onto human erythrocytes and the complexes displayed antioxidant properties as studied using ex situ square-wave voltammetry. The trial showed that silymarin in vivo may protect erythrocytes against oxidative damage.
Citace poskytuje Crossref.org
Biotransformation of Silymarin Flavonolignans by Human Fecal Microbiota
Chemo-enzymatic synthesis of silybin and 2,3-dehydrosilybin dimers